This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Codrington, A. M. Articles by Robaire, B. Search for Related Content PubMed PubMed Citation Articles by Codrington, A. M. Articles by Robaire, B.

Spermiogenic Germ Cell Phase–Specific DNA Damage Following Cyclophosphamide Exposure

BERNARD ROBAIRE^*,

From the Departments of ^* Pharmacology and Therapeutics and Obstetrics and Gynecology, McGill University, Montreal, Canada.

Correspondence to: Dr B. F. Hales, Department of Pharmacology and Therapeutics, McGill University, 3655 Promenade Sir-William-Osler, Montreal, Canada H3G 1Y6 (e-mail: barbara.hales{at}mcgill.ca).

The production of genetically competent spermatozoa is essential for normal embryo development. The chemotherapeutic drug cyclophosphamide creates cross-links and DNA strand breaks in many cell types, including germ cells. This study assessed the phase specificity of the susceptibility of spermiogenic germ cells to genetic damage induced by cyclophosphamide. Adult male rats were given cyclophosphamide using one of four schedules: 1) high dose/acute— day 1, 100 mg/kg; 2) low dose/subchronic, 4 days—days 1–4, 6.0 mg/kg/d; 3) high dose/subchronic, 4 days—day 1, 100 mg/kg, and days 2–4, 50 mg/kg/d; and 4) low dose/chronic—daily, 6.0 mg/kg/d for 14–28 days. To capture cauda epididymal spermatozoa exposed to cyclophosphamide during late, mid-, and early spermiogenesis, animals were sacrificed on days 14, 21, and 28, respectively. Spermatozoa were analyzed for DNA strand breaks using the comet assay. No dramatic increases in damage were seen after high-dose/acute exposure to cyclophosphamide. Subchronic exposure showed a dose-related increase in DNA damage; maximal damage, as demonstrated by comet tail parameters, was seen after 21 days, reflecting an increased susceptibility of step 9–14 spermatids. Low-dose chronic exposure to cyclophosphamide induced DNA damage, which reached a plateau by day 21. The magnitude of damage at all time points after low-dose chronic exposure was much greater than that following low-dose exposure for 4 days, indicating an accumulation of damage over time. Thus, the DNA damage induced by cyclophosphamide is germ cell phase–specific. The most damaging effects of cyclophosphamide occurred during a key point of sperm chromatin remodeling (histone hyperacetylation and transition protein deposition). We speculate that strand breaks disrupt chromatin remodeling, hence affecting chromatin structure and embryo development.

     Key words: Sperm, comet assay, chromatin remodeling, susceptibility, toxicology

This article has been cited by other articles:

				A. Carmely, D. Meirow, A. Peretz, M. Albeck, B. Bartoov, and B. Sredni Protective effect of the immunomodulator AS101 against cyclophosphamide-induced testicular damage in mice Hum. Reprod., June 1, 2009; 24(6): 1322 - 1329. [Abstract] [Full Text] [PDF]

				M. Rezvanfar, R. Sadrkhanlou, A Ahmadi, H Shojaei-Sadee, M. Rezvanfar, A Mohammadirad, A Salehnia, and M Abdollahi Protection of cyclophosphamide-induced toxicity in reproductive tract histology, sperm characteristics, and DNA damage by an herbal source; evidence for role of free-radical toxic stress Human and Experimental Toxicology, December 1, 2008; 27(12): 901 - 910. [Abstract] [PDF]

				C. O'Flaherty, F. Vaisheva, B.F. Hales, P. Chan, and B. Robaire Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy Hum. Reprod., May 1, 2008; 23(5): 1044 - 1052. [Abstract] [Full Text] [PDF]

				T. S. Barton, B. Robaire, and B. F. Hales DNA Damage Recognition in the Rat Zygote Following Chronic Paternal Cyclophosphamide Exposure Toxicol. Sci., December 1, 2007; 100(2): 495 - 503. [Abstract] [Full Text] [PDF]

				A. M. Codrington, B. F. Hales, and B. Robaire Chronic Cyclophosphamide Exposure Alters the Profile of Rat Sperm Nuclear Matrix Proteins Biol Reprod, August 1, 2007; 77(2): 303 - 311. [Abstract] [Full Text] [PDF]

				F. Vaisheva, G. Delbes, B. F. Hales, and B. Robaire Effects of the Chemotherapeutic Agents for Non-Hodgkin Lymphoma, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), on the Male Rat Reproductive System and Progeny Outcome J Androl, July 1, 2007; 28(4): 578 - 587. [Abstract] [Full Text] [PDF]

				A.M. Codrington, B.F. Hales, and B. Robaire Exposure of male rats to cyclophosphamide alters the chromatin structure and basic proteome in spermatozoa Hum. Reprod., May 1, 2007; 22(5): 1431 - 1442. [Abstract] [Full Text] [PDF]

				G. Delbes, B. F. Hales, and B. Robaire Effects of the Chemotherapy Cocktail Used to Treat Testicular Cancer on Sperm Chromatin Integrity J Androl, March 1, 2007; 28(2): 241 - 249. [Abstract] [Full Text] [PDF]

				A. Aguilar-Mahecha, B. F. Hales, and B. Robaire Effects of Acute and Chronic Cyclophosphamide Treatment on Meiotic Progression and the Induction of DNA Double-Strand Breaks in Rat Spermatocytes Biol Reprod, June 1, 2005; 72(6): 1297 - 1304. [Abstract] [Full Text] [PDF]

				G. Bahadur, O. Ozturk, A. Muneer, R. Wafa, A. Ashraf, N. Jaman, S. Patel, A.W. Oyede, and D.J. Ralph Semen quality before and after gonadotoxic treatment Hum. Reprod., March 1, 2005; 20(3): 774 - 781. [Abstract] [Full Text] [PDF]